Word

E

Status

Pending

Status Code

730

Status Date

Tuesday, January 16, 2024

Serial Number

97529249

Mark Type

3000

Filing Date

Monday, August 1, 2022

Published for Opposition

Tuesday, June 27, 2023

Trademark Owner History

Eli Lilly and Company - Owner At Publication

Classifications

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

The mark consists of waving ribbon-like elements that form an "E" within an incomplete circle.
Color is not claimed as a feature of the mark.

Trademark Events

Jan 18, 2024

Notice Of Approval Of Extension Request E-Mailed

Jan 16, 2024

Sou Extension 1 Granted

Jan 16, 2024

Sou Extension 1 Filed

Jan 16, 2024

Sou Teas Extension Received

Aug 22, 2023

Noa E-Mailed - Sou Required From Applicant

Jun 27, 2023

Official Gazette Publication Confirmation E-Mailed

Jun 27, 2023

Published For Opposition

Jun 7, 2023

Notification Of Notice Of Publication E-Mailed

May 24, 2023

Approved For Pub - Principal Register

May 24, 2023

Examiner's Amendment Entered

May 24, 2023

Notification Of Examiners Amendment E-Mailed

May 24, 2023

Examiners Amendment E-Mailed

May 24, 2023

Examiners Amendment -Written

May 23, 2023

Notification Of Non-Final Action E-Mailed

May 23, 2023

Non-Final Action E-Mailed

May 23, 2023

Non-Final Action Written

May 17, 2023

Assigned To Examiner

Aug 24, 2022

Notice Of Design Search Code E-Mailed

Aug 23, 2022

New Application Office Supplied Data Entered

Aug 4, 2022

New Application Entered